The $45 bln miner’s shares are off 26% in a year, and it has ditched a potential US listing. With debt constraining returns, ...

The $210 bln Ozempic maker spends less than rivals on developing new drugs. That’s a problem as upstarts challenge its ...

After a worrisome quarter in both linear and online TV, boss Bob Iger unveiled deals with the NFL and WWE. Giving the US pro football league a 10% stake in ESPN helps fortify its rollout of a ...

Since unveiling a $9 bln stock swap to buy computing power supplier Core Scientific, the buyer’s shares have tumbled 30%.

The Alpine state is scrambling to reduce the US president’s 39% tariff on imports of its goods. Shrinking its trade surplus in products like pharmaceuticals is tricky. The least-bad option is to mimic ...

CEO Stephen Dacus offered few new details on how to revive growth after rival Couche Tarde's failed $46 bln takeover. Doubling down on previous pledges, like faster store openings and listing its ...

Tata Motors' latest cross-border acquisition comes with a peculiar Indian flavour. The automaker's heavy-vehicles unit will raise equity to pay off some of the 3.8 billion euro ($4.4 billion) loan for ...

Named to the top job nearly five years ago, Jane Fraser is winning investor favor with rising returns as the bank’s share price finally reaches its book value. Praise is warranted, but with asterisks.

Shares of Match Group, owner of hook-up app Tinder, have collapsed by 80% since their peak in 2021. Fatigued younger users ...

Sweden's EQT will pay $2.7 bln for the elevator maker. It's a good outcome for pushy shareholders following a five-year grind ...

The UK fund manager has received a 6 mln pound penalty for poorly managing liquidity risks in his 10 bln pound vehicle.

Firing the top US economic statistician is the administration’s latest step in dismantling the government’s research ...